60 Participants Needed

Time-Restricted Eating for Coronary Heart Disease

(TREat-CR Trial)

Recruiting at 1 trial location
AK
Overseen ByAmy Kirkham, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Toronto
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 3 JurisdictionsThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores whether time-restricted eating (TRE) can enhance the benefits of cardiac rehabilitation for individuals with heart disease. TRE involves consuming all meals within an 8-hour window, followed by 16 hours of fasting each day, which may improve heart health when combined with exercise. Participants will either follow standard cardiac rehabilitation—a structured program of exercise and education—or add TRE to assess its impact on their recovery. Individuals with coronary artery disease or peripheral vascular disease who are open to random assignments may be suitable candidates. As an unphased trial, this study provides a unique opportunity to investigate innovative lifestyle changes that could improve heart health.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What prior data suggests that time-restricted eating is safe for individuals with coronary heart disease?

Research shows that time-restricted eating (TRE) might be a safe and effective way to improve heart health. Studies suggest that TRE can lower some risk factors for heart disease. For example, some research found that people who practice fasting, a type of TRE, may have better heart health and a lower chance of heart problems.

However, one study found a higher risk of heart issues when eating was limited to a very short time. This indicates that while TRE can be helpful, the specific timing and length of the eating period are important for safety.

Overall, TRE is generally well-tolerated, but results can vary from person to person. Consulting healthcare professionals is advisable to determine if this approach is suitable.12345

Why are researchers excited about this trial?

Researchers are excited about this trial because it explores a new approach to managing coronary heart disease by combining time-restricted eating (TRE) with standard cardiac rehabilitation. Unlike traditional treatments that focus solely on medication and exercise, this method emphasizes meal timing, encouraging participants to eat only between 11 am and 7 pm. This strategy may help improve metabolism and enhance the body's natural circadian rhythms, potentially offering additional benefits in managing heart disease. The approach is unique because it integrates dietary timing with physical activity, possibly leading to better cardiovascular outcomes.

What evidence suggests that time-restricted eating could be an effective addition to cardiac rehabilitation for coronary heart disease?

Research has shown that time-restricted eating (TRE), a type of intermittent fasting, can benefit heart health. TRE has been linked to improved blood fat levels, weight loss, and better insulin use, all of which support heart health. Some studies suggest TRE might lower risks related to heart disease, making it a promising option for prevention. However, results are mixed, as other studies have shown increased heart risks with TRE. Despite these concerns, many people have experienced better heart function with fasting practices like Ramadan. In this trial, one group of participants will receive standard cardiac rehabilitation, while another group will receive the same program with the addition of TRE. Overall, TRE could be a helpful part of heart health programs, but results can vary for each person.12367

Who Is on the Research Team?

PO

Paul Oh, MD

Principal Investigator

University Health Network, Toronto

AK

Amy Kirkham, PhD

Principal Investigator

University of Toronto, KITE Research Institute

Are You a Good Fit for This Trial?

This trial is for men and women eligible for outpatient cardiac rehabilitation due to coronary artery disease, who are willing to follow the study's procedures. It excludes those with communication barriers, night shift workers, recent mothers or pregnant women, individuals with eating disorders or very low body weight, people who eat less than 3 meals a day or have an eating window under 12 hours, and diabetics on insulin.

Inclusion Criteria

Willing to accept random assignment and complete the study assessments
My participation helps maintain gender balance in the study.
I am eligible for outpatient cardiac rehab for coronary artery disease.

Exclusion Criteria

Inability to complete the consent form and communicate in English
You eat within a time period of less than 12 hours each day, or you consistently eat fewer than 3 meals each day for the past 3 months.
You have a history of an eating disorder that you have reported yourself.
See 6 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo a 16-week cardiac rehabilitation program with or without time-restricted eating (TRE). The TRE group restricts eating to an 8-hour window daily.

16 weeks
Regular virtual education sessions and assessments

Follow-up

Participants are monitored for safety and effectiveness after treatment, including adherence to TRE and cardiac rehabilitation outcomes.

4 weeks

Long-term Follow-up

Participants are monitored for adverse events such as re-hospitalizations and recurrent cardiac events.

1 year

What Are the Treatments Tested in This Trial?

Interventions

  • Standard cardiac rehabilitation
  • Time-Restricted Eating
Trial Overview The study is testing if adding time-restricted eating (TRE), where participants eat all their meals within an 8-hour period each day, can improve the benefits of standard cardiac rehabilitation in patients with heart conditions. The effectiveness and safety of TRE as part of cardiac rehab will be evaluated.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Standard cardiac rehabilitation + TREExperimental Treatment2 Interventions
Group II: Standard cardiac rehabilitationActive Control1 Intervention

Standard cardiac rehabilitation is already approved in United States, European Union, Canada for the following indications:

🇺🇸
Approved in United States as Cardiac Rehabilitation for:
🇪🇺
Approved in European Union as Cardiac Rehabilitation for:
🇨🇦
Approved in Canada as Cardiac Rehabilitation for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Toronto

Lead Sponsor

Trials
739
Recruited
1,125,000+

University Health Network, Toronto

Collaborator

Trials
1,555
Recruited
526,000+

Published Research Related to This Trial

In a pilot study of 50 participants with obesity over 12 weeks, time-restricted eating (TRE) led to a modest average weight loss of 2.6 kg, with greater weight loss observed in those who adhered to the regimen at least five days a week.
While TRE showed similar weight loss results compared to more complex weight management methods, it did not significantly impact blood pressure or lipid profiles, suggesting its primary benefit may be in weight management rather than metabolic health.
Time restricted eating as a weight loss intervention in adults with obesity.Przulj, D., Ladmore, D., Smith, KM., et al.[2021]
High-risk cardiac patients showed significant improvements in exercise capacity (VO2peak) and heart function (LVEF) after participating in a 6 to 8 week cardiac rehabilitation program, with no serious cardiovascular events reported during the training.
The improvements in both VO2peak and LVEF in high-risk patients were comparable to those seen in control participants, indicating that cardiac rehabilitation is safe and effective for high-risk individuals.
Cardiac Rehabilitation Exercise Training for High-Risk Cardiac Patients.Choi, HE., Kim, C., Sohn, Y.[2020]
A novel telehealth-enhanced hybrid cardiac rehabilitation (THCR) program was developed using user-centered design and implementation science principles, addressing barriers to uptake identified through interviews with healthcare stakeholders.
Usability testing of the THCR prototype revealed important themes such as ease of use and technology disruptions, leading to design improvements that enhance the program's feasibility and acceptability for patients.
Applying User-Centered Design and Implementation Science to the Early-Stage Development of a Telehealth-Enhanced Hybrid Cardiac Rehabilitation Program: Quality Improvement Study.Duran, AT., Keener-DeNoia, A., Stavrolakes, K., et al.[2023]

Citations

8-hour time-restricted eating linked to a 91% higher risk of ...People who followed a pattern of eating all of their food across less than 8 hours per day had a 91% higher risk of death due to cardiovascular ...
Intermittent Fasting for the Prevention of Cardiovascular ...Modified alternate-day fasting, and time-restricted eating appear to be promising approaches for reducing most cardiovascular risk factors.
Intermittent fasting and cardiovascular disease: A scoping ...A recent observational study indicates a 91 % increased risk of CVD mortality associated with IF compared to consuming meals throughout a 12- to 16-hour period.
A perspective on intermittent fasting and cardiovascular ...Intermittent fasting has been linked to metabolic health by improving lipid profiles, reducing body weight, and increasing insulin sensitivity.
Time-Restricted Eating: A Novel Dietary Strategy for ...Among those who completed Ramadan fasting, 92% remained stable or showed an improvement in their NYHA functional classification. In summary, ...
Time Restricted Eating and Cardiac RehabilitationThis study will determine if TRE is a feasible and safe nutrition intervention during cardiac rehabilitation and if TRE improves the health benefits of cardiac ...
Time-Restricted Eating: A Novel Dietary Strategy for ...Among those who completed Ramadan fasting, 92% remained stable or showed an improvement in their NYHA functional classification. In summary, these 2 ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security